In order to confirm that Sema5b is involved in RIPC-elicited amelioration of AKI, we analyzed the concentrations of Sema5b before and 4 hours after RIPC or sham application in a cohort of cardiac surgery patients of the RIPCrenal trial (31). This evidence concerns the gene SEMA5B and acute kidney injury.